As shown in Figure 4E, the secretion of the inactive precursor of MMP-2 (pro-MMP-2) and the active form of MMP-2 were significantly reduced (-40% and -60%, respectively) in treated MM-ECs compared to controls. Here, MMP2 is linked to Miyoshi myopathy.